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Low-afﬁnity interactionsa b s t r a c t
When used in conjunction with multivalent protein probes, protein microarrays offer a robust technology
for discovery of low-afﬁnity extracellular protein–protein interactions. Probes for receptor-matching
screens generally consist of puriﬁed extracellular domains fused to afﬁnity tags. Given that approxi-
mately two-thirds of extracellular proteins are transmembrane domain-containing proteins, it would
be desirable to develop a system to express and display probe receptors in a native-like membrane
environment. Toward this end, we evaluated baculovirus display as a platform for generating multivalent
probes for protein microarray screens. Virion particles were generated displaying single-transmembrane
domain receptors BTLA, CD200, and EFNB2, representing a range of afﬁnities for their interacting part-
ners. Virions directly labeled with Cy5 ﬂuorophore were screened against a microarray containing more
than 600 extracellular proteins, and the results were compared with data derived from soluble Fc protein
or probe-coated protein A microbeads. An optimized protocol employing a blocking step with a nonre-
lated probe-expressing control baculovirus allowed identiﬁcation of the expected interactions with a sig-
nal-to-noise ratio similar to or higher than those obtained with the other formats. Our results
demonstrate that baculovirus display is suitable for detection of high- and low-afﬁnity extracellular pro-
tein–protein interactions on protein microarrays. This platform eliminates the need for protein puriﬁca-
tion and provides a native-like lipid environment for membrane-associated receptors.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Extracellular protein–protein interactions (ePPIs)1 are often
transient and low afﬁnity, making them difﬁcult to detect in screen-
ing assays [1–3]. To enhance detection, a number of probe formats
that impart signiﬁcant avidity through multimerization have
emerged. Multimeric fusion tags such as the Fc portion of human
IgG (dimer) and the coiled–coil sequence from the rat cartilage oligo-
meric matrix protein (pentamer) have been employed [4–7].
Furthermore, streptavidin- or protein A-coated microbeads have
been applied to detect weak interactions [8]. Recently, it was shown
that protein microarray technology, when combined with these
multivalent probes, is effective for studying low-afﬁnity ePPIs
[9–12].In this study, we have investigated the application of recombi-
nant baculovirus (BV) display as an alternative probe format for
protein microarrays that allows for expression of full-length trans-
membrane domain-containing proteins in a native-like lipid
bilayer and eliminates the need to directly purify the recombinant
protein using an afﬁnity tag. BV virions are enveloped in an exter-
nal phospholipid bilayer derived from the host cell surface during
egress from infected cells. By this process, BV virions selectively
incorporate the major BV glycoprotein gp64 and, presumably
through passive acquisition, other overexpressed cell surface pro-
teins [13–17]. BV display has successfully been used in antibody
development, particularly with hard-to-produce multi-transmem-
brane domain antigens [18–21]. Sakihama and coworkers success-
fully used BV display to detect several coreceptor interactions,
including a low-afﬁnity example, in enzyme-linked immunosor-
bent assay (ELISA) and cell-binding formats [22]. These results sug-
gest that the BV virion itself can serve as a multivalent probe
capable of binding to low-afﬁnity binding partners and, therefore,
might be well suited for extracellular receptor–ligand discovery
using protein microarrays.
Fig.1. Visualization of membrane proteins expressed on BV virions. Solubilized BV
virions were separated by SDS–PAGE, and the gels were probed with anti-Flag-FITC
(top) or anti-gp64-PE (bottom) and visualized using a Typhoon ﬂuorescence imager.
Roughly equivalent amounts of BV virion (10 ll of viral stock) were loaded, as
indicated by the gp64 ﬂuorescence intensity. A Flag-tagged protein control (10 ng)
was included (right-most lane), and molecular weight (MW) markers were run on
the left-most lane (a molecular weight marker running at 17 kDa showed
background ﬂuorescence in this assay). Full-length C-terminal Flag-tagged BTLA,
EFNB2, and CD200 are indicated by white asterisks.
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tor interactions: CD200/CD200R, BTLA/TNFRSF14, and EFNB2/Eph.
These cell surface receptors possess a range of binding afﬁnities
to their ligands. For example, B and T lymphocyte attenuator
(BTLA) and TNFRSF14 interact with high afﬁnity (KD  6–25 nM)
[23]. In contrast, the immune modulators CD200 and CD200R1
interact with much lower afﬁnity (KD  1 lM), and efﬁcient detec-
tion of the interaction on microarrays requires multivalent probes
[5,8,9]. The ephrin (Eph receptor interacting proteins) ligands and
Eph (erythropoietin-producing hepatocellular) family of receptor
tyrosine kinases are divided into A and B classes based on binding
preferences [24]. Within the same class, ephrins interact with Eph
receptors promiscuously and with high afﬁnity. For example, the
intra-class interaction of ephrin-B2 (EFNB2) with EphB4 has a
higher afﬁnity (KD = 40 nM) compared with the inter-class interac-
tion of EFNB2 with EphA4 (KD = 0.2–10.8 lM) [25–27]. Using these
test cases, we show here that BV display is a suitable approach for




Recombinant BV constructs were generated by restriction-
independent cloning (RIC). For each construct, separate poly-
merase chain reactions (PCRs) were prepared with two primer sets
that were appended with the following bases to incorporate sticky
ends during PCR ampliﬁcation: (i) forward A (BamH1) 50-p-GATCC
+ reverse A (EcoR1) 50-CCC and (ii) forward B (BamH1) 50-C and
reverse B (EcoR1) 50-p-AATTCCC. The PCR products were cleaned,
denatured, reannealed, and Dpn1 treated to generate PCR inserts
with sticky ends for ligation into BamHI and EcoR1 linearized RIC
vector with a pAcGP67A backbone (Pharmingen) containing a C-
terminal Flag epitope tag. All BV constructs were conﬁrmed by
DNA sequencing. The amino acid boundaries for receptor–C-term-
inal Flag fusions were BTLA (K2-S289), CD200 (E2-R267), and
EFNB2 (A2-V333).
Preparation of budded BV particles
Sf9 cells (400 ml at 2  106 cells/ml) were infected with recom-
binant BV sufﬁcient to produce a high titer viral stock (ranging
from 5.5e8 to 1.5e9 pfu/ml). Next, 72 h post-infection, cells and
large debris were removed and BV particles were isolated from
the supernatant by spinning at 38,000g (16,000 rpm) for 1.5 h in
a Beckman Centrifuge (JLA-16.250). The resulting BV pellets were
suspended in 4 ml of phosphate-buffered saline (PBS) containing
protease inhibitor cocktail (complete, ethylenediaminetetraacetic
acid [EDTA] free, Roche), creating a 100 concentrated BV suspen-
sion. Because BV instability has been associated with storage at
4 C as a result of viral particle aggregation (especially with high
viral titers) [28], and because of our own observations of decreased
activity after 1 month, we recommend that BV stocks be used soon
after their production to ensure no loss of protein function.
The expression of recombinant proteins in 100 BV solution
was conﬁrmed by ﬂuorescent detection on sodium dodecyl sul-
fate–polyacrylamide gel electrophoresis (SDS–PAGE) gels using a
Typhoon imager (GE Heathcare). Either anti-FlagM2-FITC (Sigma)
or anti-gp64-PE (Expression Systems) was used. BV samples were
incubated with 1% FC12 (n-dodecylphosphocholine) for 1 h at
4 C and then spun at 16,000g (14,000 rpm) for 35 min. A portion
of the soluble fraction was mixed with 2 SDS–PAGE sample load-
ing buffer (without reducing agent), containing 20 mM urea, with-
out boiling. After resolving by SDS–PAGE, ﬁnal detection was made
using a Typhoon imager.Protein microarray
Protein microarrays were prepared as described previously
[9,11]. Brieﬂy, recombinantly produced and puriﬁed protein sam-
ples were immobilized in duplicate spots on epoxy-derivatized
slides (Nexterion Slide E, Schott). Between each protein sample
on the microarray, BSA–Cy3 was printed in order to visualize the
spot locations and to control for sample carryover. Slides were
blocked using a fogging device with ZeptoMARK blocking buffer
BB1 (Zeptosens), followed by immersion in 5% skim milk
(LP0031, Thermo Fisher) overnight. Slides were then washed in
PBST (PBS with 0.05% Tween 20) and stored at 20 C in 40% glyc-
erol/PBS (v/v). Immediately before use, slides were warmed to
room temperature and brieﬂy rinsed with PBST.
The BV particles displaying BTLA, CD200, or EFB2 were labeled
with Amersham Cy5 monoreactive dye (GE Healthcare) in PBS at
a ratio of 5 ll of Cy5 dye to 100 ll of the 100 BV suspension at
room temperature for 15 min. The reaction was diluted by the
addition of 1 ml PBS and the BV was pelleted at 21,000g for
15 min at 4 C. The BV pellet was resuspended in 500 ll of PBS
and pelleted again, followed by resuspension in a ﬁnal volume of
100 ll PBS. Immediately prior to probing the protein microarray,
the Cy5-labeled BV was diluted 10-fold in PBS/5% skim milk, PBS/
5% skimmilk supplemented with 0.35 M NaCl, or PBS/5% skimmilk
supplemented with unlabeled control BV diluted 2.5-fold. Protein
microarray slides were processed using an automated a-Hyb
hybridization station (Miltenyi Biotech) at 15 C using the
Fig.2. Protein microarray screens using Fc proteins, microbead complexes, or BV virions. Intersection plots representing data from two replicate microarrays are shown for
BTLA, CD200, and EFNB2 probes. The plots represent data obtained using the following formats: (A) soluble Fc; (B) microbead complex; (C) BV probe without BV control
blocking; (D) BV probe with increased NaCl (500 mM) and without BV control blocking; (E) BV probe with BV control blocking. The hit cutoff is indicated by the square on the
lower left quadrant of the plot and represents the 0.0001 probability cutoff from a ﬁtted normal distribution. Hits beyond the cutoff are shown as larger dots, with the blue
and red representing non-intersection hits (exceeded the cutoff on one slide only) and the black dots representing intersection hits (exceeded the cutoff on both slides). Data
are representative of two independent BV probe lots tested for each receptor.
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(step 1), load 200 ll of unlabeled control BV diluted 10-fold in
PBS/5% skim milk and incubate for 30 min (step 2), wash ﬁve times
with PBS for 1 min (step 3), load 200 ll of Cy5-labeled BV in PBS/5%
skim milk in the presence of unlabeled control BV and incubate for
30 min (step 4), and wash ﬁve times with PBS for 1 min (step 5).
Steps 2 and 3 were omitted and step 4 was adjusted for binding
assays run in the absence of unlabeled control BV blocking.
Buffers were changed for all steps for high-salt studies. For com-
parison with BV display, recombinant Fc fusion proteins for BTLA,
CD200, and EFB2 were also probed against the extracellular protein
microarray by direct Cy5 labeling or through the formation of pro-
tein A microbead–Fc fusion complexes with Cy5–IgG as a carrier
for ﬂuorescent dye as described previously [11]. The slides were
rinsed in PBS, spun dry by centrifugation, scanned with a
GenePix 4000B scanner (Molecular Devices) for Cy3 and Cy5 ﬂuo-
rescence by exciting at 532 and 635 nm, and then analyzed using
GenePix Pro 6.0 software (Molecular Devices). Signal-to-noise
ratios were deﬁned as the average background-subtracted ﬂuores-
cent signal (F635–B635) for duplicate spots divided by the average
spot intensity (F635–B635) over the entire slide. Scores were cal-
culated according to Ramani and coworkers [9].Fig.3. EFNB2 screen images. Images are shown for individual sub-grids (F3, G1, and
L1 in Fig. S1 of the supplementary material) containing the top 3 hits in the EFNB2
probe screens. Cy5 (red) signal represents EFNB2 binding. Duplicate spots for the 3
expected interactions are outlined in white boxes in the left-most panel.Results and discussion
To explore the possibility of using recombinant BV virions as
probes for screening ePPIs on protein microarrays, Sf9 insect cells
were infected with recombinant BV, individually encoding BTLA,
CD200, or EFNB2. An intracellular C-terminal Flag tag was incorpo-
rated into each construct to allow detection by immunoblot while
leaving the extracellular domain untagged. The BV fractions were
recovered and analyzed for expression using an anti-Flag antibody
and anti-gp64 as a loading control (Fig. 1). A predominant band of
approximately 40 kDa was observed for BV-BTLA (lane 2), which is
consistent with the expected size of 31 kDa plus glycosylation.
BV-EFNB2 (lane 3) displayed one higher molecular weight band
and two smaller molecular weight bands. This pattern was
reproducible in independent preparations. The most prominent
component, running at approximately 40 kDa, likely represents
the full-length receptor (35 kDa expected), and the approximately
30- and 14-kDa bands are likely N-terminal proteolytic trunca-
tions. BV-CD200, with a theoretical molecular weight of 32 kDa,
migrated at approximately 45 kDa (lane 4). The larger size of
CD200 displayed on BV is in agreement with previously published
immunoblots of CD200 in transfected HEK293 cells and is likely
due to extensive glycosylation [29].
We previously developed an extracellular protein microarray
containing 1334 protein samples representing 686 genes [9].
Using these microarrays, we screened either Cy5-labeled soluble
Fc protein or unlabeled Fc protein in complex with protein A
microbeads (with IgG–Cy5 as a carrier of the ﬂuorescent dye).
The probe–Fc fusion proteins were screened on duplicate microar-
rays, and the top hits were identiﬁed (Fig. 2A and B; see also
Table S1 in online supplementary material). As expected, BTLA
and CD200 bound to the three independently expressed and puri-
ﬁed lots of TNFRSF14 and CD200R present on the microarrays,
respectively. The screen using soluble EFNB2-Fc displayed strong
binding signals to three (EphA7, EphB4, and EphA4) of seven highly
immobilized Eph receptors present. One additional interaction,
corresponding to a protein lot of EphB6, was identiﬁed when the
microbead complex was used. We should note that the relative
ﬂuorescent signals (and derived hit scores) for different protein
lots are not necessarily reﬂective of interaction afﬁnity given that
many factors, such as protein activity and immobilization levels
on the microarray, can play a role in determining the observedsignal [9]. The scores for individual protein lots, however, should
be comparable across assays.
Next, recombinant baculoviruses (BV-BTLA, BV-CD200, and BV-
EFNB2) were used to screen the protein microarrays. Each virus
was directly labeled with Cy5 and, as with the Fc fusions and bead
complexes, was screened in PBS containing 5% skim milk to block
nonspeciﬁc interactions (Tween 20 detergent was omitted to pre-
vent possible disruption of the BV particles). In contrast to the con-
trol screens described above, the expected interactions observed
using the BV particles were not clearly distinguished from noise
(Fig. 2C and Table S1). For example, the scores for the BV-BTLA hits
(3 lots of TNFSFR14) averaged 4.8, whereas the average for the next
10 highest scores was 4.4. The scanned microarray image for the
top 3 hits from the EFNB2 screens (Fig. 3) clearly shows an increase
in nonspeciﬁc binding.
To investigate whether this background was due to nonspeciﬁc
ionic interactions, we increased the salt concentration in the assay
buffer to 500 mM NaCl and rescreened the samples (Fig. 2D and
Table S1). For each case, the increased salt did result in reduced
nonspeciﬁc binding. However, the distinction between the true
hits and the noise was lower in each case compared with the
screens with microbead complexes. For example, the average score
for the BV-BTLA/TNFSFR14 hits was 7.7 versus an average of 5.6 for
the next top 10 highest scores. In the BTLA–Fc microbead complex
screen, the TNFRSF14 hits averaged 10.1, whereas the next top 10
highest scores averaged 5.8.
Because increasing salt did not adequately rescue signal-to-
noise ratios, we investigated an alternative blocking strategy. In this
case, an unlabeled nonrelated BV particle was used as a nonspeciﬁc
binding blocking agent. The blocked BV-BTLA screen produced
strong signals with clear separation from the noise without needing
to increase the salt concentration (Figs. 2E and 3; see also Fig. S1
and Table S1 in supplementary material). The TNFRSF14 hits for
BV-BTLA averaged 7.8, whereas the next top 10 scores averaged
3.5. Similarly, BV-EFNB2 showed strong binding signals to the same
4 ephrin receptor lots identiﬁed as hits using the microbead com-
plex, and 3 additional ephrin lots were clearly detected in the top
hits.
In summary, we have investigated the use of BV display for
application in extracellular protein–protein interaction screening
using protein microarray technology. Speciﬁc binding was success-
fully demonstrated between single-transmembrane domain recep-
tors displayed on BV virions and their ligand(s) present on the
Baculovirus display for protein microarrays / I. Tom et al. / Anal. Biochem. 479 (2015) 1–5 5protein microarray. It is likely that the avidity provided by multiple
copies of receptors on each BV virion contributed to the ability to
detect low-afﬁnity interactions. A potential advantage of BV dis-
play is that the receptors may retain lateral mobility throughout
the lipid bilayer, allowing for receptor clustering that can be
important for certain types of receptor interactions [30]. The BV
display approach also eliminates the need to directly purify the
membrane associate protein and allows for an untagged, native-
like environment. A simple centrifugation step is sufﬁcient to sepa-
rate and recover the budded virions from the infected insect cells,
and only a small amount of BV is required for screening.
Consequently, this approach can be easily miniaturized and scaled,
allowing multiple BV probes to be generated in parallel. BV display
may also be useful for screening intact heteromeric receptors or for
probing low-afﬁnity carbohydrate interactions on glycan arrays
[31]. Importantly, BV particles are known to incorporate multi-
transmembrane domain proteins [20]; therefore, BV display may
enable their screening on protein microarrays.
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